Amanote Research
Register
Sign In
OCT4 as a Target of miR-34a Stimulates P63 but Inhibits P53 to Promote Human Cell Transformation
Cell Death and Disease
- United Kingdom
doi 10.1038/cddis.2013.563
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Date
January 1, 2014
Authors
W L Ng
G Chen
M Wang
H Wang
M Story
J W Shay
X Zhang
J Wang
A R M R Amin
B Hu
F A Cucinotta
Y Wang
Publisher
Springer Science and Business Media LLC
Related search
Physical Interaction With Human Tumor-Derived P53 Mutants Inhibits P63 Activities
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Systematic Proteome Analysis Identifies Transcription Factor YY1 as a Direct Target of miR-34a
Journal of Proteome Research
Biochemistry
Chemistry
MicroRNA-34a (miR-34a)
Science-Business eXchange
Interdependent Regulation of P53 and miR-34a in Chronic Lymphocytic Leukemia
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Positive and Negative Regulation of ΔN-p63 Promoter Activity by P53 and ΔN-p63-α Contributes to Differential Regulation of P53 Target Genes
Oncogene
Cancer Research
Genetics
Molecular Biology
MiR-34a Chemosensitizes Bladder Cancer Cells to Cisplatin Treatment Regardless of P53-Rb Pathway Status
International Journal of Cancer
Cancer Research
Oncology
miR‑34a Regulates the Chemosensitivity of Retinoblastoma Cells via Modulation of MAGE‑A/p53 Signaling
International Journal of Oncology
Cancer Research
Oncology
MiR-34a Promotes DCs Development and Inhibits Their Function on T Cell Activation by Targeting WNT1
Oncotarget
Oncology
P53 Regulates Cell Cycle and MicroRNAs to Promote Differentiation of Human Embryonic Stem Cells
PLoS Biology
Immunology
Molecular Biology
Genetics
Biochemistry
Microbiology
Biological Sciences
Agricultural
Neuroscience